Marshall TG, Lee RE, Marshall FE (2006) Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Theor Biol Med Model 3:1

Article  PubMed  PubMed Central  Google Scholar 

Kostis WJ, Shetty M, Chowdhury YS, Kostis JB (2017) ACE inhibitor-induced angioedema: a review. Curr Hypertens Rep 20:1–7. https://doi.org/10.1007/s11906-018-0859-x

Article  CAS  Google Scholar 

Hargreaves KM, Roszkowski MT, Swift JQ (1993) Bradykinin and inflammatory pain. Agents Actions 41:65–73

CAS  PubMed  Google Scholar 

Byrd JB, Ram CVS, Lerma EV (2019) Pharmacologic treatment of hypertension, 4th edn. Elsevier Inc. https://doi.org/10.1016/B978-0-323-47871-7.00078-2

Book  Google Scholar 

Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111:2605–2610. https://doi.org/10.1161/CIRCULATIONAHA.104.510461

Article  CAS  PubMed  Google Scholar 

Villalobos LA, Hipólito-Luengo ÁS, Ramos González M, Cercas E, Vallejo S, Romero A, Romacho T, Carraro R, Sánchez-Ferrer CF, Peiró C (2016) The angiotensin-(1-7)/mas axis counteracts angiotensin II-dependent and -independent pro-inflammatory signaling in human vascular smooth muscle cells. Front Pharmacol 7:1–10. https://doi.org/10.3389/fphar.2016.00482

Article  CAS  Google Scholar 

Starr TN, Zepeda SK, Walls AC, Greaney AJ, Alkhovsky S, Veesler D, Bloom JD (2022) ACE2 binding is an ancestral and evolvable trait of sarbecoviruses. Nature 603:913–918. https://doi.org/10.1038/s41586-022-04464-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Felkle D, Jarczyński M, Kaleta K, Zięba K, Nazimek K (2022) The immunomodulatory effects of antihypertensive therapy: a review. Biomed Pharmacother 153:113287

Article  CAS  PubMed  Google Scholar 

Higaki A, Caillon A, Paradis P et al (2019) Innate and innate-like immune system in hypertension and vascular injury. Curr Hypertens Rep 21:4

Article  PubMed  Google Scholar 

de Vries AAF (2020) Renin-angiotensin system inhibition in COVID-19 patients. Neth Heart J 28:396–405. https://doi.org/10.1007/s12471-020-01439-5

Article  PubMed  PubMed Central  Google Scholar 

Beyerstedt S, Casaro EB, Rangel ÉB (2021) COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis 40(5):905–919. https://doi.org/10.1007/s10096-020-04138-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367:1260

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L (2020) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 17:613–620

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silhol F, Sarlon G, Deharo JC, Vaïsse B (2020) Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system? Hypertens Res 43:854–856

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murray E, Tomaszewski M, Guzik TJ (2020) Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications. Cardiovasc Res 116:e87–e89

Article  CAS  PubMed  Google Scholar 

Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme. J Biol Chem 275:33238–33243

Article  CAS  PubMed  Google Scholar 

Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14:185–192

Article  PubMed  PubMed Central  Google Scholar 

Saheb Sharif-Askari N, Saheb Sharif-Askari F, Alabed M, Temsah M-H, Al Heialy S, Hamid Q, Halwani R (2020) Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol Thera Methods Clin Dev 18:1–6

Article  CAS  Google Scholar 

Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12:8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amirian ES (2020) Potential fecal transmission of SARS-CoV-2: current evidence and implications for public health. Int J Infect Dis 95:363–370

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bradding P, Richardson M, Hinks TSC, Howarth PH, Choy DF, Arron JR, Wenzel SE, Siddiqui S (2020) ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19. J Allergy Clin Immunol 146:208–211

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mizuiri S, Ohashi Y (2015) ACE and ACE2 in kidney disease. World J Nephrol 4:74–82

Article  PubMed  PubMed Central  Google Scholar 

Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG (2020) Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med 46:1114–1116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Higham A, Singh D (2020) Increased ACE2 expression in the bronchial epithelium of COPD patients who are overweight. Obesity 28:1586–1589

Article  CAS  PubMed  Google Scholar 

Shi R, Shan C, Duan X, Chen Z, Liu P, Song J, Song T, Bi X, Han C, Wu L, Gao G, Hu X, Zhang Y, Tong Z, Huang W, Liu WJ, Wu G, Zhang B, Wang L, Qi J, Feng H, Wang F, Wang Q, Gao GF, Yuan Z, Yan J (2020) A human neutralizing antibody targets the receptor binding site of SARS-CoV-2. Nature 584:120–124

Article  CAS  PubMed  Google Scholar 

Zost SJ, Gilchuk P, Case JB, Binshtein E, Chen RE, Nkolola JP, Schäfer A, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Martinez DR, Williamson LE, Chen EC, Jones T, Day S, Myers L, Hassan AO, Kafai NM, Winkler ES, Fox JM, Shrihari S, Mueller BK, Meiler J, Chandrashekar A, Mercado NB, Steinhardt JJ, Ren K, Loo YM, Kallewaard NL, McCune BT, Keeler SP, Holtzman MJ, Barouch DH, Gralinski LE, Baric RS, Thackray LB, Diamond MS, Carnahan RH, Crowe JE Jr (2020) Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature 584(7821):443–449

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Chen C, Drelich A, Martinez DR, Gralinski LE, Sun Z, Schäfer A, Kulkarni SS, Liu X, Leist SR, Zhelev DV, Zhang L, Kim YJ, Peterson EC, Conard A, Mellors JW, Tseng CK, Falzarano D, Baric RS, Dimitrov DS (2020) Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection. Proc Natl Acad Sci U S A 117(47):29832–29838. https://doi.org/10.1073/pnas.2010197117

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hatami N, Ahi S, Sadeghinikoo A, Foroughian M, Javdani F, Kalani N, Fereydoni M, Keshavarz P, Hosseini A (2020) Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression. Endocrine 68:479–484

Article  CAS  PubMed  PubMed Central